Allan Evans

Allan Evans is Professor in Pharmaceutics and Provost & Chief Academic Officer for the University of South Australia. Allan obtained his Bachelor of Pharmacy in 1982 (South Australian Institute of Technology) and completed his Ph D in pharmacology in 1989 (University of Adelaide). After his doctorate, he spent 2 years as Research Fellow in the Department of Pharmacy at the University of Manchester. His earlier research career focussed on enantioselective pharmacokinetics and in the late 1980s he was instrumental in highlighting the problems that can be encountered when the issue of chirality is ignored when investigating the pharmacokinetics of drugs.

Much of his research career has been spent investigating the mechanisms by which drugs are transported in the intestine, liver and kidney. He is also has an active interest in the pharmacology and pharmacokinetics of the endogenous compound, L-carnitine. Over the past 20 years Allan has conducted many pre-clinical and clinical pharmacokinetic studies for Australian, European and North American pharmaceutical companies. He held NHMRC grants as chief investigator between 1992 and 2012 before moving into full time university administration, but still maintains an active research interest in several areas.

Allan's journal publications have received over 1,200 literature citations. He has supported the formation of CPR Pharma Pty Ltd.

Allan has always been concerned about the promotion and use of over the counter products for which there is little or no evidence for actual benefit. He continues to speak-out about the problems associated with what he calls 'Snake Oil Salesmen of the 21st Century'.